PPARα Activation Overcomes Fibroinflammatory Anti-PD-1 Resistance in Liver Cancer via GSDME Pyroptosis
Hepatocellular carcinoma, the most common primary cancer of the liver, has become a major testing ground for immunotherapy. Drugs that ...
Hepatocellular carcinoma, the most common primary cancer of the liver, has become a major testing ground for immunotherapy. Drugs that ...
Liver metastases are among the most difficult complications of advanced cancer. Unlike many other organs, the liver is continuously exposed ...
Rectal cancer can survive one of its most aggressive treatment combinations by turning the tissue around the tumor into a ...
CAR NK cell therapy is a novel immunotherapy made from natural killer (NK) cells engineered to better recognize and eliminate cancer cells At UT MD ...
A groundbreaking study has unveiled a novel proteomic landscape underlying SMARCA-deficient esophageal adenocarcinoma (EAC), shedding light on new mechanisms of ...
A groundbreaking discovery from Northwestern Medicine may redefine the therapeutic landscape for aggressive cancers, revealing that a well-established asthma medication ...
Chemotherapy remains a cornerstone in the fight against cancer, offering life-saving potential for many patients worldwide. However, a perplexing phenomenon ...
In a groundbreaking study published in the renowned journal Science, researchers at St. Jude Children’s Research Hospital have unveiled a ...
A groundbreaking study has unveiled a promising therapeutic avenue for one of the most lethal forms of cancer—pancreatic ductal adenocarcinoma ...
Recent advancements in the field of immunology have illuminated the intricate role of the indoleamine 2,3-dioxygenase (IDO) family within the ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine